Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aurinia Pharmaceuticals Inc

IKAP
Current price
7.61 EUR -0.058 EUR (-0.76%)
Last closed 8.33 USD
ISIN CA05156V1022
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 1 191 249 280 USD
Yield for 12 month -0.49 %
1Y
3Y
5Y
10Y
15Y
IKAP
21.11.2021 - 28.11.2021

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada. Address: 118 Avenue , 14315, Edmonton, AB, Canada, T5L 4S6

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.2 USD

P/E ratio

Dividend Yield

Current Year

+175 513 000 USD

Last Year

+134 030 000 USD

Current Quarter

+55 503 000 USD

Last Quarter

+57 192 000 USD

Current Year

+161 365 000 USD

Last Year

+128 366 000 USD

Current Quarter

+49 468 000 USD

Last Quarter

+48 283 000 USD

Key Figures IKAP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 495 000 USD
Operating Margin TTM 17.33 %
PE Ratio
Return On Assets TTM -2.16 %
PEG Ratio
Return On Equity TTM -5.78 %
Wall Street Target Price 10.2 USD
Revenue TTM 220 360 992 USD
Book Value 2.71 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 24.3 %
Dividend Yield
Gross Profit TTM 83 378 000 USD
Earnings per share -0.15 USD
Diluted Eps TTM -0.15 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -10.23 %

Dividend Analytics IKAP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IKAP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:50
Payout Ratio
Last Split Date 23.10.2013
Dividend Date

Stock Valuation IKAP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 17.452
Enterprise Value Revenue 4.222
Price Sales TTM 5.4059
Enterprise Value EBITDA 211.9261
Price Book MRQ 3.0702

Financials IKAP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IKAP

For 52 weeks

4.71 USD 10.05 USD
50 Day MA 7.13 USD
Shares Short Prior Month 7 238 554
200 Day MA 6.06 USD
Short Ratio 7.21
Shares Short 7 189 964
Short Percent 5.06 %